Benitec Biopharma
BNTC
BNTC
5 hedge funds and large institutions have $74K invested in Benitec Biopharma in 2017 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 1 increasing their positions, reducing their positions, and 0 closing their positions.
Holders
5
Holders Change
+4
Holders Change %
+400%
% of All Funds
0.12%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
1
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
Top Sellers
No sellers this quarter
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
WS
1
Wedbush Securities
Los Angeles,
California
| $50K | 26,950 | +26,950 | New |
|
|
AIM
2
Acrospire Investment Management
Chicago,
Illinois
| $13K | 7,217 | +7,217 | New |
|
3
Acadian Asset Management
Boston,
Massachusetts
| $8K | 4,159 | +4,159 | New |
|
4
UBS Group
Zurich,
Switzerland
| $2K | 1,458 | +1,208 | +483% |
|
5
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $1K | 1,000 | +1,000 | New |
|